Deen-gross Eye Centers | |
6111 Harrison St, Suite 120, Merrillville, IN 46410-2969 | |
(219) 980-6143 | |
(219) 980-6146 |
Full Name | Deen-gross Eye Centers |
---|---|
Type | Facility |
Speciality | Ophthalmology |
Location | 6111 Harrison St, Merrillville, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205156965 | NPI | - | NPPES |
000000105018 | Other | IN | ANTHEM |
100169420 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 50004042A (Indiana) | Secondary |
207W00000X | Ophthalmology | 50004042A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Deen-gross Eye Centers 6111 Harrison St, Suite 120, Merrillville, IN 46410-2969 Ph: (219) 980-6143 | Deen-gross Eye Centers 6111 Harrison St, Suite 120, Merrillville, IN 46410-2969 Ph: (219) 980-6143 |
News Archive
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).
Physicians and consumers who want fair and balanced information about the most appropriate uses for prescription medications can now find it using a Web-based resource that provides easily accessible, science-based research about drug uses free from pharmaceutical industry influence.
Baxter International Inc. announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.
Bruker Corporation (NASDAQ: BRKR) today announced the pricing of an underwritten secondary offering of 13,000,000 shares of its common stock at a price to the public of $9.85 per share.
Examining the blood "metabolomics" profile of smokers immediately after they had a cigarette revealed activation of pathways involved in cell death, inflammation, and other forms of systemic damage, say researchers at Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center.
› Verified 1 days ago